Exploring ATAD2 Bromodomain Structure And Function Differences In The Dynamic Epigenetic Landscape

被引：0
|
作者：
Malone, Kiera [1 ]
Glass, Karen [2 ]
Nix, Jay [3 ]
机构：
[1] Univ Vermont, Burlington, VT 05405 USA
[2] Albany Coll Pharm & Hlth Sci, Pharmaceut Sci, Albany, NY USA
[3] Mol Biol Consortium, Chicago, IL USA
来源：
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | 2022年 / 78卷
关键词：
D O I：
10.1107/S2053273322099648
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：A35 / A35
页数：1
相关论文
共 50 条
  • [21] ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication
    Koo, Seong Joo
    Fernandez-Montalvan, Amaury E.
    Badock, Volker
    Ott, Christopher J.
    Holton, Simon J.
    von Ahsen, Oliver
    Toedling, Joern
    Vittori, Sarah
    Bradner, James E.
    Gorjanacz, Matyas
    ONCOTARGET, 2016, 7 (43) : 70323 - 70335
  • [22] Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma
    Wu, Gang
    Lu, Xiaojun
    Wang, Yawei
    He, Hui
    Meng, Xiangyu
    Xia, Shuguan
    Zhen, Kunming
    Liu, Yongfeng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (01) : 351 - 361
  • [23] The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes
    Langini, Cassiano
    Caflisch, Amedeo
    Vitalis, Andreas
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (40) : 16734 - 16745
  • [24] Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA-damaging chemotherapy agents and radiation
    Duan, Zhijian
    Andrews, Nicolas P.
    Chen, Christopher Z.
    Fan, Ming
    Wang, Junjian
    Shen, Jing
    Li, Jian-Jian
    Chen, Hong-Wu
    ONCOLOGY REPORTS, 2020, 43 (01) : 318 - 327
  • [25] Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach
    Miller, Duncan C.
    Martin, Mathew P.
    Adhikari, Santosh
    Brennan, Alfie
    Endicott, Jane A.
    Golding, Bernard T.
    Hardcastle, Ian R.
    Heptinstall, Amy
    Hobson, Stephen
    Jennings, Claire
    Molyneux, Lauren
    Ng, Yvonne
    Wedge, Stephen R.
    Noble, Martin E. M.
    Cano, Celine
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2018, 16 (11) : 1843 - 1850
  • [26] Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2
    Poncet-Montange, Guillaume
    Zhan, Yanai
    Bardenhagen, Jennifer P.
    Petrocchi, Alessia
    Leo, Elisabetta
    Shi, Xi
    Lee, Gilbert R.
    Leonard, Paul G.
    Do, Mary K. Geck
    Cardozo, Mario G.
    Andersen, Jannik N.
    Palmer, Wylie S.
    Jones, Philip
    Ladbury, John E.
    BIOCHEMICAL JOURNAL, 2015, 466 : 337 - 346
  • [27] Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma
    Meng, Xiangyu
    Wang, Lu
    Zhu, Bo
    Zhang, Jun
    Guo, Shuai
    Li, Qiang
    Zhang, Tao
    Zheng, Zhichao
    Wu, Gang
    Zhao, Yan
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [28] Oncogenic potential of ATAD2 in stomach cancer and insights into the protein-protein interactions at its AAA plus ATPase domain and bromodomain
    Nayak, Aditi
    Kumar, Sugandh
    Singh, Shivaram Prasad
    Bhattacharyya, Asima
    Dixit, Anshuman
    Roychowdhury, Anasuya
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (12): : 5606 - 5622
  • [29] ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target
    Fu, Jiahui
    Zhang, Jin
    Chen, Xiya
    Liu, Zhiying
    Yang, Xuetao
    He, Zhendan
    Hao, Yue
    Liu, Bo
    Yao, Dahong
    THERANOSTICS, 2023, 13 (02): : 787 - 809
  • [30] Molecular docking and QSAR analysis of naphthyridone derivatives as ATAD2 bromodomain inhibitors: application of CoMFA, LS-SVM, and RBF neural network
    Bakhtyar Sepehri
    Zolaikha Rasouli
    Zeinabe Hassanzadeh
    Raouf Ghavami
    Medicinal Chemistry Research, 2016, 25 : 2895 - 2905
12345